Famotidine has fewer drug interactions than cimetidine but still requires monitoring when combined with agents dependent on gastric pH or renally eliminated medications with narrow windows.
Famotidine has fewer drug interactions than cimetidine but still requires monitoring when combined with agents dependent on gastric pH or renally eliminated medications with narrow windows.
Review severity, mechanism, and management for common interaction partners. Counsel families on when to pause therapy and when to seek urgent care.
Mechanism: Famotidine increases gastric pH, reducing absorption of acid-dependent medications.
Management: Give interacting drug at least 2 hours before famotidine. Monitor clinical response.
Mechanism: Famotidine has rare QT prolongation risk, which may potentiate effects of other QT-active drugs, especially with renal impairment.
Management: Review ECG history, monitor for palpitations, ensure electrolyte balance.
Mechanism: Additive renal burden may increase risk of accumulation; famotidine requires renal dose adjustment.
Management: Monitor renal function, adjust famotidine dosing for creatinine clearance <50 mL/min.
Mechanism: Concurrent neutralization reduces famotidine onset.
Management: Separate by at least 2 hours when possible.
Remind caregivers to share a complete medication list (including supplements), follow timing guidance, and call if new symptoms appear.
